Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06269029
Other study ID # P.T.Rec/012/004297
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 17, 2024
Est. completion date June 30, 2024

Study information

Verified date June 2024
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chest mobility exercise versus proprioceptive neuromuscular facilitation in patients with chronic obstructive pulmonary disease


Description:

The purpose of this study is designed to compare the therapeutic effect of chest mobility exercises and proprioceptive neuromuscular facilitation stretching on improving chest expansion and functional capacity in patients with chronicobstructivepulmonarydisease?


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender Male
Age group 50 Years to 60 Years
Eligibility Inclusion Criteria: All patients will have the following criteria: 1. Age: 50-60 years old 2. All patients will be in mild to moderate of COPD. In accordance with criteria of Global Initiative for Chronic Obstructive Lung Disease (GOLD) (GOLD I-II). 3. BMI: obese class 1 (30-34.9). 4. Sex: male 5. They suffered from mild dyspnea, chronic cough and expectorations, with forced expiratory volume in one second (FEV1sec) from 50% to 80% of predicted value. Exclusion criteria: Patients with the following criteria will excluded from the study: 1. Severe psychiatric or cognitive impairments. 2. Progressive neuromuscular disorders. 3. Decreased level of consciousness. 4. Unstable fracture. 5. pacemaker inserted for fewer than 2 days 6. Deep-venous thrombosis (to minimize risk for pulmonary embolism from being in a prone position. 7. Mean arterial blood pressure of less than 65 mm Hg with or without vasopressors. 8. Tracheal surgery or sternotomy in the last 15 days. 9. Massive haemoptysis. 10. Intracranial pressure of more than 30 mm Hg or cerebral perfusion pressure of less than 60 mm Hg.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Chest mobility exercises
exercises were repeated 6 times on each side with rest of period for 30 seconds in between. The intervention will be carried out for one week with total of 7 sessions. Each Exercise will be accompanied by breathing pattern. In neutral position of exercises, subjects will be asked to exhale during flexion, turning or extension subject will be asked to do inhale.
proprioceptive neuromuscular facilitation
The technique used in this study Proprioceptive neuromuscular facilitation technique of hold and relax stretching for isolated clavicular head of the pectoralis major muscle. The subjects sitting on a chair with back support to keep spine in a neutral position and both their arms are extended and hands are placed behind the occipital region. His both arms will be positioned in glenohumeral horizontal extension, and glenohumeral abduction and external rotation with elbow bent to perform stretch position of pectoral muscle. Then ask him to contract the pectoral muscles .This isometric contraction is held for 6 seconds. The patient then relaxed and passive stretch in the opposite direction . and it was repeated 6 times with rest period 30 seconds. The session will be given every day for one week

Locations

Country Name City State
Egypt Cairo university- faculty of physical therapy Cairo Dokki

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pulmonary function test Spirometry is the most common pulmonary function test. It is widely used in the assessment of lung function to provide objective information used in the diagnosis of lung diseases and monitoring lung health Test started at the time of 20 minutes after subjects inhaling 400 µg of salbutamol. The following variables were assessed: FVC, FEV1, inspiratory capacity (IC), and inspiratory reserve volume (IRV) One week for each comparator
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT04386590 - Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease. Phase 2/Phase 3
Active, not recruiting NCT04206007 - Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease Phase 1
Completed NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD N/A
Completed NCT03028142 - The Effects of RPL554 in Addition to Tiotropium in COPD Patients Phase 2
Completed NCT02962999 - Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation Phase 4
Completed NCT02998944 - The Study of CCTM and Common Diseases N/A
Completed NCT05431218 - Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD Phase 4
Completed NCT03020862 - Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients N/A
Completed NCT03031093 - Aerosol Therapy in Obese COPD Patients. N/A
Recruiting NCT06072690 - Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease